– CANADA, Vancouver – MYM Nutraceuticals Inc., (CSE: MYM)(MYM.CN) is pleased to announce that Mr. Rob Gietl has been appointed to the Company’s Board of Directors. Mr. Gietl will continue to serve as CEO of MYM.
MYM also announces that Mr. Jonathan Fiteni has resigned from the Company’s Board of Directors. Mr. Fiteni will focus on the many new business opportunities that MYM is pursuing with the upcoming legalization of recreational cannabis slated for July, 2018. Mr. Fiteni will remain Manager of Operations.
About MYM
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA: 0MY) (DEU: 0MY) (MUN: 0MY) (STU: 0MY).
For more information : http://www.mymnutraceuticals.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.